Viela Bio:
BLA for lead candidate, inebilizumab (anti-CD19 mAb), is under FDA review for the treatment of neuromyelitis optica spectrum disorder (NMOSD); PDUFA date June 11, 2020. VIB7734, anti-ILT7 mAb, Phase 1b interim data 1H20. Ph 2 trials ongoing for VIB4920 (Anti-CD40L-Tn3 Fusion Protein) in Sjogren's Syndrome and kidney transplant rejection. Additional trials with inebilizumab expected to initiate in 2020, including myasthenia gravis and IgG4-related disease.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - South Atlantic
Clinical Stage
Phase III, Phase l or ll
Disease Space
Anti-inflammatory, Autoimmune
Industry
Biotechnology
Listing
Public, USA
Market Cap
1B +
Website:
Address:
One MedImmune Way
Fifth Floor, Suite Area Two
Gaithersburg, MD 20878
United States
Fifth Floor, Suite Area Two
Gaithersburg, MD 20878
United States
Company Participants at Solebury Trout Virtual Management Access Event - 1x1 conference calls
- Zhengbin Yao, Ph.D, CEO
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Top 10 Holders of Viela Bio, Inc.
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| Hillhouse Capital Advisors Ltd. (Cayman Islands) | 9.03 | 4,591,176 | 198.71 | 13F | 2020-03-31 |
| Fidelity Management & Research Co. LLC | 8.95 | 4,549,254 | 196.89 | 13F | 2020-03-31 |
| Hillhouse Capital Advisors Ltd. | 8.51 | 4,341,176 | 187.89 | Stakes | 2019-10-03 |
| Temasek Holdings Pte Ltd. | 8.00 | 4,070,330 | 176.16 | 13F | 2020-03-31 |
| Temasek Holdings Pte Ltd. (Investment Management) | 7.98 | 4,070,330 | 176.16 | Stakes | 2019-10-07 |
| Cormorant Asset Management LP | 3.47 | 1,762,500 | 76.28 | 13F | 2020-03-31 |
| HBM Partners AG (Investment Management) | 3.42 | 1,738,329 | 75.23 | Funds | 2020-03-31 |
| Viking Global Investors LP | 2.46 | 1,250,000 | 54.10 | 13F | 2020-03-31 |
| JPMorgan Investment Management, Inc. | 1.37 | 695,942 | 30.12 | 13F | 2020-03-31 |
| ArrowMark Colorado Holdings LLC | 0.69 | 351,382 | 15.21 | 13F | 2020-03-31 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.